Schedule 13D ownership disclosure
BRIDGEBIO PHARMA INC
Security class unavailable · CUSIP: 09077J107
Event date: 2022-12-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 36,370,086
- Percent of class
- 12.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001891364-22-000004
- Form type
- SC 13D
- Filer
- Bird Global, Inc.
- CIK
- CIK 1861449
- Filed
- Dec 21, 2022
- Reporting period
- Dec 19, 2022
- Description
- Schedule 13D beneficial ownership